Product image of OXLUMO 94.5mg/0.5ml (Lumasiran) 94.5mg/0.5ml Vials supplied by GNH India

OXLUMO 94.5mg/0.5ml

Active Ingredient:
Lumasiran
Form:
Vials
Brand:
OXLUMO
Origin:
USA

OXLUMO 94.5mg/0.5ml (Lumasiran Vials) 94.5mg/0.5ml

OXLUMO 94.5mg/0.5ml (lumasiran) is a prescription medication used to treat primary hyperoxaluria type 1 (PH1). This sterile solution comes in single-use vials for subcutaneous injection. Store below 25°C and protect from light. Always follow healthcare provider guidance when using this product.

Strength

94.5mg/0.5ml

Pack Size

1s

Storage

Below 25°C

Manufacturer / TM Owner

Alnylam Pharmaceuticals, Inc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • OXLUMO 94.5mg/0.5ml is prescribed for patients with primary hyperoxaluria type 1 to reduce urinary oxalate levels. It is designed for those who require systemic treatment for this rare genetic disorder. The medication works by targeting the production of oxalate in the liver. Consult your doctor to determine if this therapy is appropriate for your condition.

Side Effects

  • After administration, OXLUMO 94.5mg/0.5ml may lead to injection site reactions such as redness or discomfort. Some patients report mild fatigue or headache following treatment. These effects are generally temporary and vary by individual. Monitor your response and discuss any concerns with your healthcare provider.

Precautions & Warnings

  • Keep OXLUMO 94.5mg/0.5ml vials refrigerated or stored below 25°C away from direct light. Do not freeze or shake the vial. Always check the solution for particles or discoloration before use. Dispose of used vials properly according to local regulations. Inform your doctor of any allergies or sensitivities before starting treatment.

Avoid Interactions

  • Certain medications may affect how OXLUMO 94.5mg/0.5ml works, including CYP enzyme modulators and other drugs processed in the liver. Avoid alcohol during treatment unless approved by your physician. Always disclose all medications and supplements to your healthcare provider to assess potential interactions.

Frequently Asked Questions

OXLUMO 94.5mg/0.5ml is used to treat primary hyperoxaluria type 1 (PH1) by reducing oxalate production in the body.

It is given as a subcutaneous injection, typically by a healthcare professional, using the provided single-use vial.

Common effects may include injection site reactions, mild fatigue, or headache. These are usually temporary.

Yes, it can be stored below 25°C but should not be frozen or exposed to direct light.

It may interact with certain liver-processed drugs; always inform your doctor about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lumasiran

Oxlumo

Oxlumo

94.5mg/0.5ml Vials
OXLUMO 94.5mg/0.5ml

OXLUMO 94.5mg/0.5ml

94.5mg/0.5ml Vials
Oxlumo (lumasiran)

Oxlumo (lumasiran)

94.5 mg/.5mL INJECTION, SOLUTION

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT